Biocon Biologics Uk Ltd
Clinical trials sponsored by Biocon Biologics Uk Ltd, explained in plain language.
-
New psoriasis drug goes Head-to-Head with established treatment
Disease control CompletedThis study tested a new drug called Bmab 1200 against an already approved drug, Stelara, to see if it works as well for controlling moderate to severe plaque psoriasis. About 384 adults with this skin condition received one of the two drugs for a year, and researchers measured ho…
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New bone drug goes Head-to-Head with market leader
Disease control CompletedThis study tested whether a new osteoporosis drug called Bmab 1000 works as well as the established medication Prolia. Researchers enrolled 479 postmenopausal women with osteoporosis and randomly assigned them to receive either the new drug or Prolia via injection every six month…
Phase: PHASE3 • Sponsor: Biocon Biologics UK Ltd • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC